Far upstream element-binding protein 1 and rna secondary structure both mediate second-step splicing repression

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 29, 2013, Pages

  Li, Huang ^a   Wang, Zhijia ^a   Zhou, Xuexia ^a   Cheng, Yuanming ^a   Xie, Zhiqin ^a   Manley, James L ^b   Feng, Ying ^a,c  

^a Chinese Academy of Sciences   (China)

^b Columbia University ^*  (United States)

^c BEIJING HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; FAR UPSTREAM ELEMENT BINDING PROTEIN 1; MESSENGER RNA PRECURSOR; RNA BINDING PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; EXON; EXON SKIPPING; FEMALE; GENE OVEREXPRESSION; GENE SEQUENCE; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; RNA INTERFERENCE; RNA SECONDARY STRUCTURE; RNA SPLICING; RNA STRUCTURE;

BASE SEQUENCE; BINDING SITES; BLOTTING, WESTERN; DNA HELICASES; DNA PRIMERS; DNA-BINDING PROTEINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; EXONS; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA INTERFERENCE; RNA SPLICING;

EID: 84880365282     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1310607110     Document Type: Article

References (63)

1. Zhou Z, Licklider LJ, Gygi SP, Reed R (2002) Comprehensive proteomic analysis of the human spliceosome. Nature 419(6903)-182-185.
2. Jurica MS, Moore MJ (2003) Pre-mRNA splicing: Awash in a sea of proteins. Mol Cell 12(1):5-14.
3. Singh RK, Cooper TA (2012) Pre-mRNA splicing in disease and therapeutics. Trends Mol Med 18(8):472-482.
4. David CJ, Chen M, Assanah M, Canoll P, Manley JL (2010) HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature 463(7279): 364-368.
5. Chen M, Manley JL (2009) Mechanisms of alternative splicing regulation: Insights from molecular and genomics approaches. Nat Rev Mol Cell Biol 10(11):741-754.
6. Nilsen TW, Graveley BR (2010) Expansion of the eukaryotic proteome by alternative splicing. Nature 463(7280):457-463.
7. Licatalosi DD, Darnell RB (2010) RNA processing and its regulation: Global insights into biological networks. Nat Rev Genet 11(1):75-87.
8. Ule J, et al. (2006) An RNA map predicting Nova-dependent splicing regulation. Nature 444(7119):580-586.
9. Zhou HL, Lou H (2008) Repression of prespliceosome complex formation at two distinct steps by Fox-1/Fox-2 proteins. Mol Cell Biol 28(17):5507-5516.
10. Wang Z, et al. (2004) Systematic identification and analysis of exonic splicing silencers. Cell 119(6):831-845.
11. Yu Y, et al. (2008) Dynamic regulation of alternative splicing by silencers that modulate 5′ splice site competition. Cell 135(7)-1224-1236.
12. Zhang XH, Chasin LA (2004) Computational definition of sequence motifs governing constitutive exon splicing. Genes Dev 18(11)-1241-1250.
13. Lallena MJ, Chalmers KJ, Llamazares S, Lamond AI, Valcárcel J (2002) Splicing regulation at the second catalytic step by Sex-lethal involves 3′ splice site recognition by SPF45. Cell 109(3):285-296.
14. Grover A, et al. (1999) 5′ splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10. J Biol Chem 274(21)-15134-15143.
15. Hiller M, Zhang Z, Backofen R, Stamm S (2007) Pre-mRNA secondary structures influence exon recognition. PLoS Genet 3(11):e204.
16. Warf MB, Berglund JA (2010) Role of RNA structure in regulating pre-mRNA splicing. Trends Biochem Sci 35(3)-169-178.
17. Jin Y, Yang Y, Zhang P (2011) New insights into RNA secondary structure in the alternative splicing of pre-mRNAs. RNA Biol 8(3):450-457.
18. Halfter H, Gallwitz D (1988) Impairment of yeast pre-mRNA splicing by potential secondary structure-forming sequences near the conserved branchpoint sequence. Nucleic Acids Res 16(22)-10413-10423.
19. Lin J, Rossi JJ (1996) Identification and characterization of yeast mutants that overcome an experimentally introduced block to splicing at the 3′ splice site. RNA 2(8):835-848.
20. Feng Y, et al. (2009) SRp38 regulates alternative splicing and is required for Ca(2+) handling in the embryonic heart. Dev Cell 16(4):528-538.
21. Feng Y, Chen M, Manley JL (2008) Phosphorylation switches the general splicing repressor SRp38 to a sequence-specific activator. Nat Struct Mol Biol 15(10)-1040-1048.
22. Duncan R, et al. (1994) A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new DNA-binding motif. Genes Dev 8(4):465-480.
23. Olanich ME, Moss BL, Piwnica-Worms D, Townsend RR, Weber JD (2011) Identification of FUSE-binding protein 1 as a regulatory mRNA-binding protein that represses nucleophosmin translation. Oncogene 30(1):77-86.
24. Zheng Y, Miskimins WK (2011) Far upstream element binding protein 1 activates translation of p27Kip1 mRNA through its internal ribosomal entry site. Int J Biochem Cell Biol 43(11)-1641-1648.
25. Labourier E, et al. (1999) Recognition of exonic splicing enhancer sequences by the Drosophila splicing repressor RSF1. Nucleic Acids Res 27(11):2377-2386.
26. Gruber AR, Lorenz R, Bernhart SH, Neubock R, Hofacker IL (2008) The Vienna RNA websuite. Nucleic Acids Res 36(Web Server issue):W70-W74.
27. He L, et al. (2000) Loss of FBP function arrests cellular proliferation and extinguishes cmyc expression. EMBO J 19(5)-1034-1044.
28. Zhang Z, Harris D, Pandey VN (2008) The FUSE binding protein is a cellular factor required for efficient replication of hepatitis C virus. J Virol 82(12):5761-5773.
29. Irwin N, Baekelandt V, Goritchenko L, Benowitz LI (1997) Identification of two proteins that bind to a pyrimidine-rich sequence in the 3′-untranslated region of GAP- 43 mRNA. Nucleic Acids Res 25(6)-1281-1288.
30. Min H, Turck CW, Nikolic JM, Black DL (1997) A new regulatory protein, KSRP, mediates exon inclusion through an intronic splicing enhancer. Genes Dev 11(8): 1023-1036.
31. Labourier E, Adams MD, Rio DC (2001) Modulation of P-element pre-mRNA splicing by a direct interaction between PSI and U1 snRNP 70K protein. Mol Cell 8(2):363-373.
32. Cukier CD, et al. (2010) Molecular basis of FIR-mediated c-myc transcriptional control. Nat Struct Mol Biol 17(9)-1058-1064.
33. Benjamin LR, et al. (2008) Hierarchical mechanisms build the DNA-binding specificity of FUSE binding protein. Proc Natl Acad Sci USA 105(47)-18296-18301.
34. Lebedeva S, et al. (2011) Transcriptome-wide analysis of regulatory interactions of the RNA-binding protein HuR. Mol Cell 43(3):340-352.
35. Förch P, et al. (2000) The apoptosis-promoting factor TIA-1 is a regulator of alternative pre-mRNA splicing. Mol Cell 6(5)-1089-1098.
36. Förch P, Puig O, Martínez C, Séraphin B, Valcárcel J (2002) The splicing regulator TIA-1 interacts with U1-C to promote U1 snRNP recruitment to 5′ splice sites. EMBO J 21(24): 6882-6892.
37. Zhu H, Hasman RA, Young KM, Kedersha NL, Lou H (2003) U1 snRNP-dependent function of TIAR in the regulation of alternative RNA processing of the human calcitonin/CGRP pre-mRNA. Mol Cell Biol 23(17):5959-5971.
38. Liu J, et al. (2000) The FBP interacting repressor targets TFIIH to inhibit activated transcription. Mol Cell 5(2):331-341.
39. Braddock DT, Louis JM, Baber JL, Levens D, Clore GM (2002) Structure and dynamics of KH domains from FBP bound to single-stranded DNA. Nature 415(6875)-1051-1056.
40. Dean JL, Sully G, Clark AR, Saklatvala J (2004) The involvement of AU-rich elementbinding proteins in p38 mitogen-Activated protein kinase pathway-mediated mRNA stabilisation. Cell Signal 16(10)-1113-1121.
41. Ince-Dunn G, et al. (2012) Neuronal Elav-like (Hu) proteins regulate RNA splicing and abundance to control glutamate levels and neuronal excitability. Neuron 75(6): 1067-1080.
42. Hinman MN, Lou H (2008) Diverse molecular functions of Hu proteins. Cell Mol Life Sci 65(20):3168-3181.
43. Gal-Mark N, Schwartz S, Ram O, Eyras E, Ast G (2009) The pivotal roles of TIA proteins in 5′ splice-site selection of alu exons and across evolution. PLoS Genet 5(11): e1000717.
44. Izquierdo JM, et al. (2005) Regulation of Fas alternative splicing by antagonistic effects of TIA-1 and PTB on exon definition. Mol Cell 19(4):475-484.
45. Spellman R, Llorian M, Smith CW (2007) Crossregulation and functional redundancy between the splicing regulator PTB and its paralogs nPTB and ROD1. Mol Cell 27(3): 420-434.
46. Boutz PL, et al. (2007) A post-transcriptional regulatory switch in polypyrimidine tractbinding proteins reprograms alternative splicing in developing neurons. Genes Dev 21(13)-1636-1652.
47. Rabenhorst U, et al. (2009) Overexpression of the far upstream element binding protein 1 in hepatocellular carcinoma is required for tumor growth. Hepatology 50(4)-1121-1129.
48. Malz M, et al. (2009) Overexpression of far upstream element binding proteins: A mechanism regulating proliferation and migration in liver cancer cells. Hepatology 50(4)-1130-1139.
49. Weber A, et al. (2008) The FUSE binding proteins FBP1 and FBP3 are potential c-myc regulators in renal, but not in prostate and bladder cancer. BMC Cancer 8:369.
50. Singer S, et al. (2009) Coordinated expression of stathmin family members by far upstream sequence element-binding protein-1 increases motility in non-small cell lung cancer. Cancer Res 69(6):2234-2243.
51. Bettegowda C, et al. (2011) Mutations in CIC and FUBP1 contribute to human oligodendroglioma. Science 333(6048)-1453-1455.
52. Shultz JC, et al. (2011) SRSF1 regulates the alternative splicing of caspase 9 via a novel intronic splicing enhancer affecting the chemotherapeutic sensitivity of non-small cell lung cancer cells. Mol Cancer Res 9(7):889-900.
53. Di Modugno F, et al. (2012) Splicing program of human MENA produces a previously undescribed isoform associated with invasive, mesenchymal-like breast tumors. Proc Natl Acad Sci USA 109(47)-19280-19285.
54. Berasain C, et al. (2010) Impairment of pre-mRNA splicing in liver disease: Mechanisms and consequences. World J Gastroenterol 16(25):3091-3102.
55. David CJ, Manley JL (2010) Alternative pre-mRNA splicing regulation in cancer: Pathways and programs unhinged. Genes Dev 24(21):2343-2364.
56. Shepard PJ, Hertel KJ (2008) Conserved RNA secondary structures promote alternative splicing. RNA 14(8)-1463-1469.
57. Zhang J, Kuo CC, Chen L (2011) GC content around splice sites affects splicing through pre-mRNA secondary structures. BMC Genomics 12:90.
58. House AE, Lynch KW (2006) An exonic splicing silencer represses spliceosome assembly after ATP-dependent exon recognition. Nat Struct Mol Biol 13(10):937-944.
59. Sharma S, Kohlstaedt LA, Damianov A, Rio DC, Black DL (2008) Polypyrimidine tract binding protein controls the transition from exon definition to an intron defined spliceosome. Nat Struct Mol Biol 15(2)-183-191.
60. Zuo P, Manley JL (1994) The human splicing factor ASF/SF2 can specifically recognize pre-mRNA 5′ splice sites. Proc Natl Acad Sci USA 91(8):3363-3367.
61. Shi Y, Manley JL (2007) A complex signaling pathway regulates SRp38 phosphorylation and pre-mRNA splicing in response to heat shock. Mol Cell 28(1):79-90.
62. Hall MP, Huang S, Black DL (2004) Differentiation-induced colocalization of the KHtype splicing regulatory protein with polypyrimidine tract binding protein and the c-src pre-mRNA. Mol Biol Cell 15(2):774-786.
63. Kashima T, Manley JL (2003) A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy. Nat Genet 34(4):460-463.